Bert from New Zealand

Registered at the short selling broker Kriptomat, 2 minutes ago.

» Try Kriptomat you too
Don't show again

Tilray, Inc. (TLRY) shares information

Tilray work with cultivation of GMP-certified medical cannabis, along with marijuana research, processing and distribution.

Tilray Inc – Class 2


24h Change

-6.95 %

TLRY

Live rate: Market closed

Stock data per Monday 10 May, 2021

TLRY
NASDAQ/NGS (GLOBAL SELECT MARKET)
16.18
15.06
-1.125 (-6.95%)
US Market is closed

Live Stock price in graph for Tilray Inc – Class 2 (TLRY)

  • Latest Volume

    29,610,981 (-60.43 %)

  • Volume prev. day

    74,836,278

  • Avg. daily volume

    22,553,137

  • Market cap

    2,700,146,980

  • P/E ratio

    -7

  • Today high

    n/a

  • Today low

    n/a

  • 52 week high

    67 USD

  • 52 week low

    4.41 USD

  • YTD Change

    + 88.93 %

About Tilray Inc

Tilray shares had their all time high at $148 in October, 2018. Tilray reached all time low at $2.47 at 18th of March, 2020.

Website: https://www.tilray.com
Twitter: @tilray
Instagram: @tilray

Potential risks to be aware of with this company/stock

– Still a lot of costs before showing true profitability.

– Considerably smaller and higher share price fluctuation than market leader Canopy Growth (CGC).

– Supply / demand imbalances is still a risk factor in Tilray shares.

Potential upsides beneficial to the company/stock

+ Not correlated to many other sectors, which can be both positive and negative.

+ Still no news about any THC drinks together with Anheuser-Busch InBev, that was expected 6 months ago, Bloomberg's article.

Quick links

 

Latest news about Tilray Inc – Class 2

Below you can find the most recent news posts about Tilray Inc – Class 2, primarily from US and UK based news sources.

The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More

Friday, 7 May 2021, 23:36:03
This was an eventful week for the cannabis industry. On Monday, Tilray, Inc. (NASDAQ: TLRY ) and Aphria, Inc. (NASDAQ: APHA ) closed their merger after months of negotiations, creating a company with a combined market cap of $3.3 billion. Benzinga spoke with Irwin Simon, CEO of the new combined company. Check out the video below: Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23. Jazz Pharmaceuticals (NASDAQ: JAZZ ) finalized its acquisition of GW Pharmaceuticals plc. (NASDAQ: GWPH ), the producer of the FDA‑approved prescription cannabidiol drug Epidiolex, for $7.2 billion or $6.7 billion net of GW Pharma's cash. Meanwhile, Ascend Wellness Holdings (CSE: AAWH) started trading on the Canadian Securities exchange following a raise of approximately $80 million through an initial public offering of roughly 10 million shares of its Class A common stock at $8 per share. Benzinga Cannabis’ content is now available in Spanish on El Planteo .
— Benzinga


Tilray Stock Is Getting Squeezed Between 2 Key Levels

Friday, 7 May 2021, 22:06:16
Tilray Inc. (NASDAQ: TLRY ) shares were trading higher Friday after a Jefferies analyst double upgraded the stock. The stock was double upgraded from Underperform to Buy and the price target was raised from $4.77 to $23. Tilray recently closed a merger with Aphria Inc. (NASDAQ: APHA ). Click here to read more about why Tilray is moving. Tilray was up 14.7% at $16.23 ahead of the market close Friday. Tilray Daily Chart Analysis The stock is getting squeezed between a previous support and a potential resistance line. The stock may see a strong move in the upcoming weeks. The stock is trading below the 50-day moving average (green) and above the 200-day moving average (blue), indicating the stock is likely trading in a period of consolidation. The … Full story available on Benzinga.com
— Benzinga


Latest Upgrades and Downgrades: Tilray, Peloton and Roku – TheStreet

Friday, 7 May 2021, 21:02:34
TheStreet's weekly guide to upgrades, downgrades and price-target changes includes Tilray, Peloton, Clorox and Roku.
— The Street


Looking Into Tilray's Return On Capital Employed

Friday, 7 May 2021, 17:59:51
Tilray (NASDAQ: TLRY ) reported Q4 sales of $56.56 million. Earnings fell to a loss of $19.79 million, resulting in a 36.87% decrease from last quarter. Tilray collected $51.41 million in revenue during Q3, but reported earnings showed a $31.35 million loss. What Is Return On Capital Employed? Changes in earnings and sales indicate shifts in Tilray's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests … Full story available on Benzinga.com
— Benzinga


5 Top Stock Gainers for Friday: Roku, Tilray, Datadog – TheStreet

Friday, 7 May 2021, 17:49:29
Roku, Tilray, Datadog, Bill.com and Golden Entertainment are five top stock gainers for Friday.
— The Street


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have TLRY available or trade one of the many other CFD stocks they have.
Risk warning: 71.2% of retail investor accounts lose money when trading CFDs with Capital.